Germany Cell and Gene Therapy Market Report 2023: Players Include Novartis, Gilead Sciences, Spark Therapeutics, Amgen and Orchard Therapeutics – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Germany Cell and Gene Therapy Market – Focused Insights 2023-2028” report has been added to ResearchAndMarkets.com’s offering. The Germany cell and gene therapy market was valued at $0.34 billion in 2022 and is projected to reach at $3.44 billion in 2028, with a compound annual growth rate (CAGR) of 40.15%, during the study … [Read more…]

Global Gastrointestinal Agents Industry Report to 2030: North America Dominates the Market – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Gastrointestinal Agents Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030” report has been added to ResearchAndMarkets.com’s offering. The report offers strategic insights into the overall gastrointestinal agents market along with the market size and estimates for the duration 2020 to 2030. Companies … [Read more…]

LabGenius Appoints Prof Hendrik-Tobias Arkenau and Prof Victor Greiff as Scientific Advisors

Prominent oncology clinician Prof Hendrik-Tobias Arkenau and computational antibody design expert Prof Victor Greiff will bolster LabGenius’ leadership in the field of machine learning-driven antibody discovery. LONDON–(BUSINESS WIRE)–#AI–LabGenius, a pioneer in the use of machine learning (ML) for antibody discovery, today announced that accomplished scientific leaders Hendrik-Tobias Arkenau, MD/PhD/FRCP, and Victor Greiff, PhD, will join … [Read more…]

PHC Corporation and NovaScan, Inc. Launch Collaboration to Explore the Feasibility of a Device that Supports Non-melanoma Skin Cancer Detection

TOKYO–(BUSINESS WIRE)–PHC Corporation (headquarters: Minato-ku, Tokyo, President: Nobuaki Nakamura, hereafter PHC) and NovaScan, Inc. (headquarters: Chicago, Illinois, CEO: Craig Davis, hereafter NovaScan) announce the launch of a collaboration through which they will seek to explore the feasibility of MarginScanTM, an investigational “ex vivo” (outside the body) medical device that will seek to support physicians in … [Read more…]

BioDuro-Sundia Wins Life Sciences Review Top 10 BPO Award

IRVINE, Calif.–(BUSINESS WIRE)–Life Sciences Review magazine recognizes BioDuro-Sundia as a top 10 Business Process Outsourcing (BPO). BioDuro-Sundia earned this award for its high-quality service and cutting-edge technology, as well as its integrated contract research, development and manufacturing (CRDMO) service platforms. Dr. Kent Payne, CEO of BioDuro-Sundia, accepted the award. In an exclusive interview with Life … [Read more…]

InnoCare Announces First Subject Dosed in Clinical Trial of Novel Targeted Protein Degrader ICP-490 in China

BEIJING–(BUSINESS WIRE)–InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the first subject has been dosed in clinical trial of the Company’s novel targeted protein degrader ICP-490 in China. ICP-490 is developed from InnoCare’s molecular glue platform for the treatment of multiple … [Read more…]

AGC Biologics Signs Exosome Agreement with The Jikei University in Japan for Idiopathic Pulmonary Fibrosis (IPF) Project

SEATTLE–(BUSINESS WIRE)–AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced it signed a service agreement with The Jikei University in Japan. Under the agreement, AGC Biologics will assume a technology transfer and feasibility study for a drug product focused on the treatment of Idiopathic pulmonary fibrosis at the CDMO’s center of … [Read more…]

Ur24Technology Receives Medicare Reimbursement for Revolutionary External Catheter System

Decision by US Dept of Health & Human Services paves the way for sales growth of TruClr, first product designed to actively empty the bladder, as company pushes into new markets NEWPORT BEACH, Calif.–(BUSINESS WIRE)–Ur24 Technology, Inc., a privately-held medical device company, has cleared a key hurdle to grow sales of its revolutionary external catheter … [Read more…]

Delic Holdings Corp. Signs LOI with Peter/PetraMD to Acquire Ketamine Wellness Centers and Facilitate Online Ketamine Treatments Nationwide

VANCOUVER, British Columbia–(BUSINESS WIRE)–Peter/PetraMD, the largest online provider of hormone therapy for men and women in the United States, today announced the intent to acquire Ketamine Wellness Centers. If successful, the acquisition would represent an incredible on-ramp into the ketamine space for Peter/PetraMD. With over 20 years of experience and nearly 100,000 patients across the … [Read more…]